
In a 48-patient phase 1b trial, ecnoglutide was well tolerated in adolescents with obesity and reduced BMI up to 12.6% at 20 weeks.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in Pediatrics that looked at the connections between maternal and paternal obesity and childhood development issues.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in Pediatrics that looked at the connections between maternal and paternal obesity and childhood development issues.






